1. Holmes FA, Walters RS, Theriault RL, et al: Phase II trial of taxol, an active drug in metastatic breast cancer. J Natl Cancer Inst 83: 1797–1805, 1991
2. Neidhart JA: Hematopoietic colony-stimulating factors. Cancer 70: 913–920, 1992
3. Dogliotti L, Berruti A, Burriva T, Zola P, Barí MG, Farris A, Sarobba MG, Bottini A, Alquati P, Deltetto F, Gosso P, Manzeglio C, Moro G, Sussio M, Perroni D: A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study. Int J Oncol 4: 741–746, 1994
4. Clark GM: Do we really need prognostic factors for breast cancer? Breast Cancer Res Treat 30: 117–126, 1994
5. Osborne CK: Receptors. In: Harris JR, Hellman S, Henderson JC, Kinne DW (eds), Breast Disease. Lippincott, Philadelphia, pp. 301–305, 1991